Alvarado F, Van Os CH [1986] [eds] Ion gradient-coupled transport. Elsevier Science Publishers, Amsterdam, pp 442
Google Scholar
Atanasova S, von Ahsen N, Dimitrov T, Armstrong V, Oellerich M, Toncheva D [2004] MDR1 haplotypes modify BEN disease risk: a study in Bulgarian patients with Balkan endemic nephropathy compared to healthy controls. Nephron Exp Nephrol 96:7–13
Google Scholar
Athayde AL, Ivory CF [1985] Electrical pumping in carrier-mediated membrane transport. J Membr Sci 24:309–323
CAS Google Scholar
Ayrton A, Morgan P [2001] Role of transport proteins in drug absorption, distribution and excretion. Xenobiotica 31:469–497
PubMed CAS Google Scholar
Bilej M, Vetvicka V [1989] The transmembrane and intracellular transport of drugs: interactions with the cytosceletal network. Crit Rev Ther Drug Carrier Syst 6:613–691
PubMed CAS Google Scholar
Bolhuis H, van Veen HW, Poolman B, Driessen AJ, Konings WN [1997] Mechanisms of multidrug transporters. FEMS Microbiol Rev 21:55–84
PubMed CAS Google Scholar
Borst P, Oude Elferink R [2002] Mammalian ABC transporters in health and disease. Annu Rev Biochem 71:537–592
PubMed CAS Google Scholar
Brant SR, Panhuysen CI, Nicolae D, Reddy DM, Bonen DK, Karaliukas R, Zhang L, Swanson E, Datta LW, Moran T, Ravenhill G, Duerr RH, Achkar JP, Karban AS, Cho JH [2003] MDR1 Ala893 polymorphism is associated with inflammatory bowel disease. Am J Hum Genet 73:1282–1292
PubMed CAS Google Scholar
Brodie BB [1964] Physico-chemical factors in drug absorption. In: Binns TB [ed] Absorption and distribution of drugs. Livingstone, Edinburgh, pp 16–48
Google Scholar
Brodie BB, Hogben CAM [1957] Some physico-chemical factors in drug action. J Pharmacy Pharmacol 9:345–380
CAS Google Scholar
Burckhardt BC, Burckhardt G [2003] Transport of organic anions across the basolateral membrane of proximal tubule cells. Rev Physiol Biochem Pharmacol 146:95–158
PubMed CAS Google Scholar
Burckhardt G, Wolff NA [2000] Structure of renal organic anion and cation transporters. Am J Physiol Renal Physiol 278:F853–F866
PubMed CAS Google Scholar
Caldwell PC [1956] The effects of certain metabolic inhibitors on the phosphate esters of the squid giant axon. J Physiol [London] 132:35
CAS Google Scholar
Caldwell PC [1960] The phosphorus metabolism of squid axons and its relationship to the active transport of sodium. J Physiol [London] 152:545–560
CAS Google Scholar
Carafoli E, Scarpa A [1982] [eds] Transport-ATPases. Ann N Y Acad Sci, New York [402]:604
Google Scholar
Catania VA, Sanchez Pozzi EJ, Luquita MG, Ruiz ML, Villanueva SS, Jones B, Mottino AD [2004] Co-regulation of expression of phase II metabolizing enzymes and multidrug resistance-associated protein 2. Ann Hepatol 3:11–17
PubMed Google Scholar
Chan LMS, Lowes S, Hirst BH [2004] The ABCs of drug transport in intestine and liver: efflux proteins limiting drug absorption and bioavailability. Eur J Pharmaceut Sci 21:25–51
CAS Google Scholar
Chandra P, Brouwer KL [2004] The complexities of hepatic drug transport: current knowledge and emerging concepts. Pharm Res 21:719–735
PubMed CAS Google Scholar
Crane RK, Krane SM [1959] Studies on the mechanism of intestinal active transport of sugars. Biochim Biophys Acta 31:397–401
PubMed CAS Google Scholar
Dahlquist R, Ejvinsson G, Schenk-Gustaffson K [1980] Effect of quinidine on plasma concentration and renal clearance of digoxin. A clinically important drug interaction. Brit J Clin Pharmacol 9:413–418
Google Scholar
Daniel H [2004] Molecular and integrative physiology of intestinal peptide transport. Annu Rev Physiol 66:361–384
PubMed CAS Google Scholar
Daniel H, Rubio-Aliaga I [2003] An update on renal peptide transporters. Am J Physiol Renal Physiol 284:F885–F892
PubMed CAS Google Scholar
Dean M, Rzhetsky A, Allikmets R [2001] The human ATP-binding cassette [ABC] transporter superfamily. Genome Res 11:1156–1166
PubMed CAS Google Scholar
Delgoda R, Westlake AC [2004] Herbal interactions involving cytochrome p450 enzymes: a mini review. Toxicol Rev 23:239–249
PubMed CAS Google Scholar
DeVree J, Jacquemin E, Sturm E, Creteil D, Bosma PJ, Aten J, DeLeuze JF, Desrochers M, Burdelski M, Bernard O, Oude Elferink RP, Hadchouel M [1998] Mutations in the MDR3 gene cause progessive familial intahepatic cholestasis. Proc Natl Acad Sci USA 95:282–287
CAS Google Scholar
Diamond JM,Wright EM [1969] Biological membranes: the physical basis of ion and nonelectrolyte selectivity. Annu Rev Physiol 31:581–646
PubMed CAS Google Scholar
Dietrich CG, Geier A, Oude Elferink RPJ [2003] ABC or oral bioavailability: transporters as gatekeepers in the gut. Gut 52:1788–1795
PubMed CAS Google Scholar
Doering W [1979] Quinidine-digoxin interaction: Pharmacokinetics, underlying mechanism and clinical implications. N Engl J Med 301:400–404
Article PubMed CAS Google Scholar
Donner MG, Keppler D [2001] Up-regulation of basolateral multidrug resistance protein 3 [Mrp3] in cholestatic rat liver. Hepatology 34:351–359
PubMed CAS Google Scholar
Drescher S, Schaeffeler E, Hitzl M, Hofmann U, Schwab M, Brinkmann U, Eichelbaum M, Fromm MF [2002] MDR1 gene polymorphisms and disposition of the P-glycoprotein substrate fexofenadine. Br J Clin Pharmacol 53:526–534
PubMed CAS Google Scholar
Drescher S, Glaser H, Mürdter T, Hitzl M, Eichelbaum M, Fromm MF [2003] P-glycoprotein-mediated intestinal and biliary digoxin transport in humans. Clin Pharmacol Ther 73:223–231
PubMed CAS Google Scholar
Dresser MJ, Leabman MK, Giacomini KM [2001] Transporters involved in the elimination of drugs in the kidney: organic anion transporters and organic cation transporters. Pharmaceut Sci 90:397–420
CAS Google Scholar
Dresser GK, Bailey DG, Leake BF, Schwarz UI, Dawson PA, Freeman DJ, Kim RB [2002] Fruit juices inhibit organic anion transporting polypeptide-mediated drug uptake to decrease the oral availability of fexofenadine. Clin Pharmacol Ther 71:11–20
PubMed CAS Google Scholar
Drozdzik M, Bialecka M, Mysliwiec K, Honczarenko K, Stankiewicz J, Sych Z [2003] Polymorphism in the P-glycoprotein drug transporter MDR1 gene: a possible link between environmental and genetic factors in Parkinson’s disease. Pharmacogenetics 13:259–263
PubMed CAS Google Scholar
Elleroy JC, Lew VL [1977] [eds] Membrane transport in red cells. Academic Press, New York, pp 469
Google Scholar
Fardel O, Jigorel E, Le Vee M, Payen L [2005] Physiological, pharmacological and clinical features of the multidrug resistance protein 2. Biomed Pharmacother 59:104–114
PubMed CAS Google Scholar
Fehrenbach T, Cui Y, Faulstich H, Keppler D [2003] Characterization of the transport of the bicyclic peptide phalloidin by human hepatic transport proteins. Naunyn-Schmiedeberg’s Arch Pharmacol 368:415–420
CAS Google Scholar
Fromm MF [2004] Importance of P-glycoprotein at blood-tissue barriers. Trends Pharmacol Sci 25:423–429
PubMed CAS Google Scholar
Fromm MF, Kim RB, Stein CM, Wilkinson GR, Roden DM [1999] Inhibition of P-glycoprotein-mediated drug transport: a unifying mechanism to explain the interaction between digoxin and quinidine. Circulation 99:552–557
PubMed CAS Google Scholar
Gao B, St Pierre MV, Stieger B, Meier PJ [2004] Differential expression of bile salt and organic anion transporters in developing rat liver. J Hepatol 41:202–208
Google Scholar
Gerok W, Sickinger K [1973] [eds] Drugs and the liver. Schattauer Verlag, Stuttgart, pp 441
Google Scholar
Geyer J, Döring B, Godoy JR, Moritz A, Petzinger E [2005a] Development of a PCR-based diagnostic test detecting a nt230[del4] MDR1 mutation in dogs: verification in a moxidectin-sensitive Australian Shepherd. J Vet Pharmacol Ther 28:95–99
PubMed CAS Google Scholar
Geyer J, Döring B, Godoy JR, Moritz A, Petzinger E [2005b] Frequency of the nt230[del4] MDR1 mutation in Collies and related dog breeds from Germany. J Vet Pharmacol Ther 28:545–551
PubMed CAS Google Scholar
Geyer J, Wilke T, Petzinger E [2006] The solute carrier family SLC10: more than a family of bile acid transporters regarding function and phylogenetic relationships. Naunyn-Schmiedeberg’s Arch Pharmacol, this issue
Gilles-Baillieu M, Gilles R [1983] [eds] Intestinal transport: fundamental and comparative aspects. Springer-Verlag, Berlin Heidelberg New York, pp 375
Google Scholar
Gillette JR [1963] Metabolism of drugs and other foreign compounds by enzymatic mechanisms. Progr Drug Res 6:11–75
CAS Google Scholar
Grammatté T, Oertel R [1999] Intestinal secretion of intravenous talinolol is inhibited by luminal R-verapamil. Clin Pharmacol Ther 66:239–245
Google Scholar
Grammatté T, Oertel R, Terhaa, B, Kirch W [1996] Direct demonstration of small intestinal secretion and side-dependent absorption of the β-blocker talinolol in human. Clin Pharmacol Ther 59:541–549
Google Scholar
Greiner B, Eichelbaum M, Fritz P, Kreichgauer HP, von Richter O, Zundler J, Kroemer HK [1999] The role of intestinal P-glycoprotein in the interaction of digoxin and rifampin. J Clin Invest 104:147–153
PubMed CAS Google Scholar
Greger R, Lang F, Silbernagl S [1981] [eds] Renal transport of organic substances. Springer-Verlag, Berlin Heidelberg New York, pp 314
Google Scholar
Gründemann D, Gorboulev V, Gambaryan S, Veyhl M, Koepsell H [1994] Drug excretion mediated by a new prototype of polyspecific transporter. Nature 372:549–552
PubMed Google Scholar
Habig WH, Pabst MJ, Fleischner G, Gatmaitan Z, Arias IM, Jacobvy WB [1974] The identity of glutathione S-transferase B with ligandin, a major binding protein of liver. Proc Natl Acad Sci USA 71:3879–3882
PubMed CAS Google Scholar
Hagenbuch B, Meier PJ [2003] The superfamily of organic anion transporting polypeptides. Biochim Biophys Acta 1609:1–18
PubMed CAS Google Scholar
Haimeur A, Conseil G, Geeley RG, Cole SP [2004] The MRP-related and BCRP/ABCG2 multidrug resitance proteins: biology, substrate specificity and regulation. Curr Drug Metab 5:21–53
PubMed CAS Google Scholar
Hediger MA, Coady MJ, Ikeda TS, Wright EM [1987] Expression cloning and cDNA sequencing of the Na+/glucose cotransporter. Nature [London] 330:379–381
CAS Google Scholar
Hediger MA, Romero MF, Peng JB, Rolfs A, Takanaga H, Bruford EA [2004] The ABCs of solute carriers: physiological, pathological, and therapeutic implications of human membrane transport proteins. Pfluegers Arch 447:465–468
CAS Google Scholar
Heinz E [1972] [eds] Na-linked transport of organic solutes. The coupling between electrolyte and nonelectrolyte transport in cells. Springer-Verlag, Berlin Heidelberg New York, pp 201
Google Scholar
Heinz E [1978] [eds] Mechanics and energetics of biological transport. Springer-Verlag, Berlin Heidelberg New York, pp 159
Google Scholar
Hoffmann U, Kroemer HK [2004] The ABC transporters MDR1 and MRP2: multiple functions in disposition of xenobiotics and drug resistance. Drug Metab Rev 86:669–701
Google Scholar
Hoffmeyer S, Burk O, von Richter O, Arnold H P, Brockmöller J, Johne A, Cascorbi I, Gerloff T, Roots I, Eichelbaum M, Brinkmann U [2000] Functional polymorphisms of the human multidrug-resitance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc Nat Acad Sci U S A 97:3473–3478
CAS Google Scholar
Hogben CAM, Tocco DJ, Brodie BB, Schanker LS [1959] On the mechanism of intestinal drug absorption of drugs. J Pharmacol Exp Ther 125:275–282
PubMed CAS Google Scholar
Homolya L, Varadi A, Sarkadi B [2003] Multidrug resitance-assiciated proteins: export pumps for conjugates with glutathione, glucuronate or sulfate. Biofactors 17:103–114
PubMed CAS Google Scholar
Hsiang B, Zhu Y, Wang Z, Wu Y, Sasseville V, Yang WP, Kirchgessner TG [1999] A novel human hepatic organic anion transporting polypeptide [OATP2] Identification of a liver-specific human organic anion transporting polypeptide and identification of rat and human hydroxymethylglutaryl-CoA reductase inhibitor transporters. J Biol Chem 274:37161–37168
PubMed CAS Google Scholar
Ieiri I, Takane H, Otsubo K [2004] The MDR1 [ABCB1] gene polymorphism and its clinical implications. Clin Pharmacokinet 43:553–576
PubMed CAS Google Scholar
Iida A, Saito S, Sekine A, Mishima C, Kondo K, Kitamura Y, Harigae S, Osawa S, Nakamura Y [2001] Catalog of 258 single-nucleotide polymorphisms [SNPs] in genes encoding three organic anion transporters, three organic anion transporting polypeptides, and three NADH : ubichinone oxidoreductase flavoproteins. J Hum Genet 46:668–683
PubMed CAS Google Scholar
Ito K, Iwatsuro T, Kanamitsu S, Ueda K, Suzuki H, Sugiyama Y [1998] Prediction of pharmacokinetic alterations caused by drug-drug interactions: metabolic interaction in the liver. Pharmacol Rev 50:387–411
PubMed CAS Google Scholar
Jackson MJ [1987] Drug transport across gastrointestinal epithelia. In: LR Johnson [ed] Physiology of the gastrointestinal tract. Raven Press, New York, pp 1597–1621
Google Scholar
Jacquemin E, Hagenbuch B, Stieger B, Wolkoff AW, Meier PJ [1994] Expression cloning of a rat liver Na[+]-independent organic anion transporter. Proc Natl Acad Sci USA 91:133–137
PubMed CAS Google Scholar
Juliano RL, Ling V [1976] A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim Biophys Acta 455:152–162
PubMed CAS Google Scholar
Jansen PLM [2001] Hereditary defects of hepatobiliary transport. In: Matern S, Boyer JL, Keppler D, Meier-Abt PJ [eds] Hepatobiliary transport: from bench to bedside. Kluwer Acad. Publ., Dordrecht, pp 91–97
Google Scholar
Kafka A, Sauer G, Jaeger C, Grundmann R, Kreienberg R, Zeillinger R, Deissler H [2003] Polymorphism C3435T of the MDR-1 gene predicts response to preoperative chemotherapy in locally advanced breast cancer. Int J Oncol 22:1117–1121
PubMed CAS Google Scholar
Keynes RD [1961] The energy source for active transport in nerve and muscle. In: A Kleinzeller, A Kotyk [eds] Membrane transport and metabolism. Academic Press, London, pp 131–139
Google Scholar
Kilby JM, Hill A, Buss N [2002] The effect of ritonavir on saquinavir plasma concentration is independent of ritonavir dosage: combined analysis of pharmacokinetic data from 97 subjects. HIV Med 3:97–104
PubMed CAS Google Scholar
Kim RB [2004] 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors [statins] and genetic variability [single nucleotide polymorphisms] in a hepatic drug uptake transporter: what’s it all about? Clin Pharmacol Ther 75:381–385
PubMed CAS Google Scholar
Kim RB, Fromm MF, Wandel C, Leake B, Wood AJJ, Roden DM, Wilkinson GR [1998] The drug transporter p-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors. J Clin Invest 101:289–294
PubMed CAS Google Scholar
Klaassen CD, Watkins JB [1984] Mechanisms of bile formation, hepatic uptake, and biliary excretion. Pharmacol Rev 36:1–67
PubMed CAS Google Scholar
Koepsell H, Endou H [2004] The SLC22 drug transporter family. Pflügers Arch 447:666–676
PubMed CAS Google Scholar
König J, Rost D, Cui Y, Keppler D [1999] Characterisation of the human multidrug resistance protein isoform MRP3 localized to the basolateral hepatocyte membrane. Hepatology 29:1156–1163
PubMed Google Scholar
König J, Seithel A, Gradhand U, Fromm MF [2006] Pharmacogenomics of human OATP transporters. Naunyn-Schmiedeberg’s Arch Pharmacol, this issue
Kramer M, Lauterbach F [1977] [eds] Intestinal permeation. Excerpta Medica, Amsterdam, pp 449
Google Scholar
Kramer W, Wess G [1996] Bile acid transport systems as pharmaceutical targets. Eur J Clin Invest 26:715–732
PubMed CAS Google Scholar
Kramer W, Wess G, Schubert G, Bickel M, Girbig F, Gutjahr U, Kowalewski S, Baringshaus K-H, Ehnsen A, Glombik H, Müllner S, Neckermann G, Schulz S, Petzinger E [1992] Liver-specific drug trageting by coupling with bile acids. J Biol Chem 267:18598–18604
PubMed CAS Google Scholar
Kramer W, Sauber K, Baringhaus K-H, Kurz M, Stengelin S, Lange G, Corsiero D, Girbig F, König W, Weyland C [2001] Identification of the bile acid-binding site of the ileal lipid-binding protein by photoaffinty labelling, matrix-assisted laser desorption ionization-mass spectrometry, and NMR structure. J Biol Chem 276:7291–7301
PubMed CAS Google Scholar
Krusekopf S, Roots I [2005] St. John’s wort and its constituent hyperforin concordantly regulate expression of genes encoding enzymes involved in basic cellular pathways. Pharmacogenetics 15:817–829, Genomics
CAS Google Scholar
Kubitz R, Keitel V, Häussinger D [2005] Inborn errors of biliary canalicular transport systems. Meth Enzymol 400:558–569
PubMed CAS Google Scholar
Kullak-Ublick GA, Beuers U, Paumgartner G [2000] Hepatobiliary transport. J Hepatol 32:3–18
PubMed CAS Google Scholar
Kullak-Ublick GA, Stieger B, Meier PJ [2004] Enterohepatic bile salt transporters in normal physiology and liver disease. Gastroenterology 126:322–342
PubMed CAS Google Scholar
LeFevre PG [1948] Evidence of active transfer of certain non-electrolytes across the human red cell membrane. J Gen Physiol 31:505–507
CAS PubMed Google Scholar
LeFevre PG [1975] The present state of the carrier hypothesis. In: Bronner F, Kleinzeller A [eds] Current topics in membranes and transport. Academic Press, London, pp 109–215
Google Scholar
Leslie EM, Deeley RG, Cole SP [2001] Toxicological relevance of the multidrug resistance protein 1, MRP1 [ABCC1] and related transportes. Toxicology 167:3–23
PubMed CAS Google Scholar
Leslie EM, Deeley RG, Cole SP [2005] Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2 and BCRP [ABCG2] in tissue defense. Toxicol Appl Pharmacol 204:216–237
PubMed CAS Google Scholar
Levi AJ, Gatmaitan Z, Arias IM [1969] Two hepatic cytoplasmic protein fractions, Y and Z, and their possible role in the hepatic uptake of bilirubin, sulfobromophthalein, and other anions. J Clin Invest 48:2156–2167
PubMed CAS Google Scholar
Liu L, Pang KS [2005] The roles of transporters and enzymes in hepatic drug processing. Drug Metab Dispos 33:1–9
PubMed Google Scholar
Lloyd JB [2000] Lysosome membrane permeability: implications for drug delivery. Adv Drug Deliv Rev 41:189–200
PubMed CAS Google Scholar
Maisonnette F, Abita T, Barriere E, Pichon N, Vincensini JF, Descottes B [2005] The MDR3 gene mutation: a rare cause of progressive familial intrahepatic cholestasis [PFIC]. Ann Chir 130:581–583
PubMed CAS Google Scholar
Mannel M [2004] Drug interactions with St John’s wort: mechanisms and clinical implications. Drug Saf 27:773–797
PubMed CAS Google Scholar
Mealey KL, Bentjen SA, Gay JM, Cantor GH [2001] Ivermectin sensitivity in collies is associated with a deletion mutation in the mdr1 gene. Pharmacogenetics 11:727–733
PubMed CAS Google Scholar
Meijer DK [1993] Drug targeting to the liver with bile acids: the “Trojan horse” resurrected? Hepatology 17:945–948
PubMed CAS Google Scholar
Milne RW, Larsen LA, Jorgensen KL, Bastlund JF, Stretch GL, Evans AM [2000] Hepatic disposition of fexofenadine: influence of the transport inhibitors erythromycin and dibromosulphothalein. Pharmaceutical Res 17:1511–1515
CAS Google Scholar
Mizuno N, Niwa T, Yotsumoto Y, Sugiyama Y [2003] Impact of drug transporter studies on drug discovery and development. Pharmacol Rev 55:425–461
PubMed CAS Google Scholar
Müller M, Jansen PLM [1998] The secretory step of the liver: new aspects of hepatobiliary transport. J Hepatol 28:344–354
PubMed Google Scholar
Murray JW, Wolkoff AW [2003] Roles of the cytoskeleton and motor proteins in endocytic sorting. Adv Drug Deliv Rev 55:1385–1403
PubMed CAS Google Scholar
Niemi M, Schaeffeler E, Lang T, Fromm MF, Neuvonen M, Kyrklund C, Backman J T, Kerb R, Schwab M, Neuvonen PJ, Eichelbaum M, Kivistö KJ [2004] High plasma pravastatin concentrations are associated with single nucleotide polymorphisms and haplotypes of organic anion transporting polypeptide-C [OATP-C, SCLO1B1]. Pharmacogenetics 14:429–440
PubMed CAS Google Scholar
Niemi M, Neuvonen PJ, Hofmann U, Backman JT, Schwab M, Lütjohann D, von Bergmann K, Eichelbaum M, Kivistö KT [2005a] Acute effects of pravastatin on cholesterol synthesis are associated with SCLO1B1 [encoding OATP1B1] haplotype *17. Pharmacogen Genom 15:303–309
Article CAS Google Scholar
Niemi M, Kivistö KT, Hofmann U, Schwab M, Eichelbaum M, Fromm M [2005b] Fexofenadine pharmacokinetics are associated with a polymorphism of the SCLO1B1 gene [encoding OATP1B1]. Br J Clin Pharmacol 59:602–604
PubMed CAS Google Scholar
Nozawa T, Nakajima M, Tamai I, Noda K, Nezu JI, Sai Y, Tsuji A, Yokoi T [2002] Genetic polymorphisms of human organic anion transporters OATP-C [SLC21A6] and OATP-B [SLC21A9]: allele frequencies in the Japanese population and functional studies. J Pharmacol Exp Ther 302:804–813
PubMed CAS Google Scholar
Ogawa K, Suzuki H, Hirohashi T, Ishikawa T, Meier PJ, Hirose K, Akizawa T, Yoshioka M, Sugiyama Y [2000] Characterization of inducible nature of MRP3 in rat liver. Am J Physiol Gastrointest Liver Physiol 278:G438–G446
PubMed CAS Google Scholar
Ohashi M, Sano N, Takikawa H [2002] Effects of phalloidin on the biliary excretion of cholephilic compounds in rats. Pharmacology 66:31–35
PubMed CAS Google Scholar
Paul AJ, Tranquilli WJ, Seward RL, Todd KS, DiPietro JA [1987] Clinical observations in collies given ivermectin orally. Am J Vet Res 48:684–685
PubMed CAS Google Scholar
Pauli-Magnus C, Meier PJ [2004] Pharmacogenetics of hepatocellular transporters. Pharmacogenetics 13:189–198
Google Scholar
Paulusma LC, Oude Elferink RP [1997] The canalicular multispecific anion transporter and conjugated hyperbilirubinemia in rat and man. J Mol Med 75:420–428
PubMed CAS Google Scholar
Pedersen KE, Christansen BD, Klittgaard NA, Nielsen-Kudsk F [1983] Effect of quinidine of digoxin bioavailability. Eur J Clin Pharmacol 24:41–47
PubMed CAS Google Scholar
Petzinger E [1981] Competitive inhibition of the uptake of demethylphalloin by cholic acid in isolated hepatocytes. Evidence for a transport competition rather than a binding competition. Naunyn-Schmiedeberg’s Arch Pharmacol 316:345–349
CAS Google Scholar
Petzinger E [1994] Transport of organic anions in the liver. An update on bile acid, fatty acid, monocarboxylate, anionic amino acid, cholephilic organic anion, and anionic drug transport. Rev Physiol Biochem Pharmacol 123:47–211
Article PubMed CAS Google Scholar
Petzinger E, Ziegler K, Frimmer M [1979] Inhibition of 3H-demethylphalloin uptake in isolated rat hepatocytes under various experimental conditions. Naunyn-Schmiedeberg’s Arch Pharmacol 307:275–281
CAS Google Scholar
Petzinger E, Kinne RKH, Sies H [1989] [eds] Hepatic transport of organic substances. Springer-Verlag, Berlin Heidelberg New York, pp 435
Google Scholar
Petzinger E, Nickau L, Horz JA, Schulz S, Wess G, Ehnsen A, Falk E, Baringhaus K-H, Glombik H, Hoffmann A, Müllner S, Nekermann G, Kramer W [1995] Hepatobiliary transport of hepatic 3-hydroxy-3-methylglutaryl Coenzyme A reductase inhibitors conjugated with bile acids. Hepatology 22:1801–1811
PubMed CAS Google Scholar
Pritchard JB, Miller DS [1993] Mechanisms mediating renal secretion of organic anions and cations. Physiol Rev 73:765–796
PubMed CAS Google Scholar
Pulliam JD, Seward RL, Henry RT, Steinberg SA [1985] Investigating ivermectin toxicity in Collies. Vet Med 80:33–40
Google Scholar
Roninson IB, Chin JE, Choi KG, Gros P, Housman DE, Fojo A, Shen DW, Gottesman MM, Pastan I [1986] Isolation of human mdr DNA sequences amplified in multidrug resistant KB carcinoma cells. Proc Natl Acad Sci U S A 83:4538–4542
PubMed CAS Google Scholar
Rosenberg T, Wilbrandt W [1957] Uphill transport induced by counterflow. J Gen Physiol 41:289–296
PubMed CAS Google Scholar
Rost D, Kartenbeck J, Keppler D [1999] Changes in the localization of the rat canalicular conjugate export pump Mrp2 in phalloidin-induced cholestasis. Hepatology 29:814–821
PubMed CAS Google Scholar
Roulet A, Puel O, Gesta S, Lepage JF, Drag M, Soll M, Alvinerie M, Pineau T [2003] MDR1-deficient genotype in Collie dogs hypersensitive to the P-glycoprotein substrate ivermectin. Eur J Pharmacol 460:85–91
PubMed CAS Google Scholar
Russel FG, Masereeuw R, Van Aubel RA [2002] Molecular aspects of renal anionic drug transport. Annu Rev Physiol 64:563–594
PubMed CAS Google Scholar
Scheffer GL, Kool M, de Haas M, de Vree JM, Pijnenborg AC, Bosman DK, Oude Elferink R, Van Borst P, Scheper RJ [2002] Tissue distribution and induction of human multidrug resistant protein 3. Lab Invest 82:193–201
PubMed CAS Google Scholar
Schwab M, Schaeffeler E, Marx C, Fromm MF, Kaskas B, Metzler J, Stange E, Herfarth H, Schoelmerich J, Gregor M, Walker S, Cascorbi I, Roots I, Brinkmann U, Zanger UM, Eichelbaum M [2003] Association between the C3435T MDR1 gene polymorphism and susceptibility for ulcerative colitis. Gastroenterology 124:26–33
PubMed CAS Google Scholar
Sekine T, Watanabe N, Hosoyamada M, Kanai Y, Endou H [1997] Expression cloning and characterization of a novel multispecific organic anion transporter. J Biol Chem 272:18526–18529
PubMed CAS Google Scholar
Semenza G, Kinne R [1985] [eds] Membrane transport driven by ion gradients. Ann N Y Acad Sci 456:459
Shibayama Y, Ikeda R, Motoya T, Yamada K [2004] St John’s Wort [Hypericum perforatum] induces overexpression of multidrug resistance protein2 [MRP2] in rats: a 30-day ingestion study. Food Chem Toxicol 42:995–1002
PubMed CAS Google Scholar
Shoda J, Kano M, Oda K, Kamiya J, Nimura Y, Suzuki H, Sugiyama Y, Miyazaki H, Todoroki T, Stengelin S, Kramer W, Matsuzaki Y, Tanaka N [2001] The expression levels of plasma membrane transporters in the cholestatic liver of patients undergoing biliary drainage and their association with the impairment of biliary secretory function. Am J Gastroenterol 96:3368–3378
PubMed CAS Google Scholar
Siegsmund M, Brinkmann U, Schaffeler E, Weirich G, Schwab M, Eichelbaum M, Fritz P, Burk O, Decker J, Alken P, Rothenpieler U, Kerb R, Hoffmeyer S, Brauch H [2002] Association of the P-glycoprotein transporter MDR1[C3435T] polymorphism with the susceptibility to renal epithelial tumors. J Am Soc Nephrol 13:1847–1854
PubMed CAS Google Scholar
Smith JN, Williams RT [1949] The metabolism of phenacetin [p-ethoxyacetanilide] in the rabbit and a further observation on acetanilide metabolism. Biochem J 44:239–242
CAS Google Scholar
Soroka CJ, Lee JM, Azzaroli F, Boyer JL [2001] Cellular localization and up-regulation of multidrug resistance-associated protein 3 in hepatocytes and cholangiocytes during obstructive cholestasis in rat liver. Hepatology 33:783–791
PubMed CAS Google Scholar
Spahn-Langguth H, Baktir G, Radschuweit A, Okyar A, Terhaag B, Ader P, Hanafy A, Langguth P [1998] P-glycoprotein transporters and the gastrointestinal tract: evaluation of the potential in vivo relevance of in vitro data employing talinolol as model compound. Int J Clin Pharmacol Ther 36:16–24
PubMed CAS Google Scholar
Sperber I [1959] Secretion of organic anions in formation of urine and bile. Pharmacol Rev 11:109–134
PubMed CAS Google Scholar
Stein W [1967] [ed] The movement of molecules across membranes. Academic Press, New York, pp 367
Google Scholar
Sweet DH, Wolff NA, Pritchard JB [1997] Expression cloning and characterization of ROAT1 The basolateral organic anion transporter in rat kidney. J Biol Chem 272:30088–30095
PubMed CAS Google Scholar
Synold TW, Dussault I, Forman BM [2001] The orphan nuclear receptor SXR coordinately regulated drug metabolism and efflux. Nature Med 7:584–590
PubMed CAS Google Scholar
Tirona RG, Kim RB [2002] Pharmacogenomics of drug transporters. In: J Licinio, M-L Wing [eds] Pharmacogenomics: the search for individualized therapies. Wiley-VCH, pp 179–213
Tirona RG, Leake BF, Merino G, Kim RB [2001] Polymorphisms in OATP-C: Identification of multispecific allelic variants associated with altered transport activity among European- and African-Americans. J Biol Chem 276:35669–35675
PubMed CAS Google Scholar
Trauner M, Boyer JL [2003] Bile salt transporters: molecular characterization, function, and regulation. Physiol Rev 83:633–671
PubMed CAS Google Scholar
Trauner M, Meier PJ, Boyer JL [1998] Molecular pathogenesis of cholestasis. N Engl J Med 339:1217–1227
PubMed CAS Google Scholar
Trauner M, Wagner M, Fickert P, Zollner G [2005] Molecular regulation of hepatobiliary transport systems: clinical implications for understanding and treating cholestasis. J Clin Gastroenterol 39:S111–S124
PubMed Google Scholar
Ullrich KJ [1997] Renal transporters for organic anions and organic cations. Structural requirements for substrates. J Membr Biol 158:95–107
PubMed CAS Google Scholar
Van Heeswijk RP, Veldkamp A, Mulder JW, Meenhorst PL, Lange JM, Beijnen JH, Hoetelmans RM [2001] Combination of protease inhibitors for the treatment of HIV-1-infected patients: a review of pharmacokinetics and clinical experience. J Antivir Ther 6:201–229
Google Scholar
Van Montfoort JE, Hagenbuch B, Groothuis GMM, Koepsell H, Meier PJ, Meijer DKF [2003] Drug uptake systems in liver and kidney. Curr Drug Metab 4:185–211
PubMed Google Scholar
Wagner M, Trauner M [2005] Transcriptional regulation of hepatobiliary transport systems in health and disease: implications for a rationale approach to the treatment of intrahepatic cholestasis. Ann Hepatol 4:77–99
PubMed CAS Google Scholar
Wandel C, Kim RB, Kajiji S, Guengerich FP, Wilkinson GR, Wood AJJ [1999] P-glycoprotein and cytochrome P-450 3 A inhibition: dissociation of inhibitory potencies. Cancer Res 59:3944–3948
PubMed CAS Google Scholar
Ward WJ III [1970] Electrically induced carrier transport. Nature 227:162–163
PubMed CAS Google Scholar
Washington CB, Wiltshire HR, Man M, Moy T, Harris SR, Worth E, Weigl P, Liand Z, Hall D, Marriot L, Blaschke TF [2000] The disposition of saquinavir, in normal and P-glycoprotein deficient mice, rats, and cultured cells. Drug Metab Disp 28:1058–1062
CAS Google Scholar
Watson P, Jones AT, Stephens DJ [2005] Intracellular trafficking pathways and drug delivery: fluorescence imaging of living and fixed cells. Adv Drug Deliv Rev 57:43–61
PubMed CAS Google Scholar
Weaver JL, Pine PS, Aszalos A, Schoenlein PV, Currier SJ, Padmanabhan R, Gottesman MM [1991] Laser scanning and confocal microscopy of daunorubicin, doxorubicin, and rhodamine 123 in multi-drug resistant cells. Exp Cell Res 196:323–329
PubMed CAS Google Scholar
Westphal K, Weinbrenner A, Zschiesche M, Franke G, Knoke M, Oertel R, Fritz P, von Richter O, Warzok R, Hachenberg T, Kaumann HM, Schrenk D, Terhaag B, Kroemer HK, Siegmund W [2000] Induction of P-glycoprotein by rifampin increases intestinal secretion of talinolol in human beings: a new type of drug/drug interaction. Clinical Pharmacol Ther 68:345–355
CAS Google Scholar
Wilbrandt W [1975] Criteria in carrier transport. In: H Eisenberg, E Katchalski-Kazir, LA Manson [eds] Biomembranes vol 7. Plenum Press New York, London, pp 11–31
Google Scholar
Williams RT [1959] [ed] Detoxification mechanisms the metabolism and detoxification of drugs, toxic substances and other organic compounds. Chapman & Hall, London, pp 796
Google Scholar
Wright EM, Turk E [2004] The sodium/glucose cotransport family SLC5. Pflügers Arch-Eur J Physiol 447:510–518
CAS Google Scholar
Yarim M, Moro S, Huber R, Meier PJ, Kaseda C, Kashima T, Hagenbuch B, Folkers G [2005] Application of QSAR analysis to organic anion polypeptide 1a5 [Oatp 1a5] substrates. Bioorg Med Chem 13:463–471
PubMed CAS Google Scholar
Zhang Y, Guo X, Tin ET, Benet LZ [1998] Overlapping substrate specificities of cytochrome P450 3A and P-glycoprotein for a novel cysteine protease inhibitor. Drug Metab Disp 26:360–366
CAS Google Scholar
Ziegler K, Hummelsiep S [1993] Hepatoselective carrier-mediated sodium-independent uptake of pravastatin and pravastatin-lactone. Biochim Biophys Acta 1153:23–33
PubMed CAS Google Scholar
Ziegler K, Stünkel W [1992] Tissue-selective action of pravastatin due to hepatocellular uptake via a sodium-independent bile acid transporter. Biochim Biophys Acta 1139:203–209
PubMed CAS Google Scholar